Retina Foundation Presents at Largest Retina Meeting in China
Retina China 2018, a prestigious meeting held March 28-30 in Qingdao, China, was well attended by retinal specialists from all over Asia with only a handful invited from the United States, including Dr. Karl Csaky, Managing & Medical Director of the Retina Foundation of the Southwest. Having been invited to present at this meeting, Dr. Csaky used this opportunity to speak about the new OCT-A machine recently acquired by the Retina Foundation. This new cutting-edge technology enables our researchers to obtain detailed information on the retinal layers, blood vessels, blood flow, and more in patients with age-related macular degeneration. Dr. Csaky’s talk highlighted the importance of this new technology in helping diagnose and treat patients with age-related macular degeneration.
About Dr. Karl G. Casky
Karl G. Csaky, M.D., Ph.D. is the Managing & Medical Director, Director of the Molecular Ophthalmology Laboratory, and the T. Boone Pickens Senior Scientist at the Retina Foundation of the Southwest. Dr. Csaky’s main area of research is age-related macular degeneration, on which he conducts both laboratory and clinical research.
About Age-Related Macular Degeneration
Age-related macular degeneration (AMD) is the number one cause of vision loss for people over the age of 65. It is a common retinal disease that disrupts the central vision that is necessary for everyday tasks such as reading, writing, and driving. Age-related macular degeneration occurs when there is a loss of visual cells (rods and cones) from the macula, the central part of the retina.
Related ArticlesChance Encounter Leads to Early Diagnosis and Treatment for Kate The Edward C. Fogg, III and Lisbeth A. Fogg Charitable Trust grants Retina Foundation $133,000 for Genetic Eye Disease International Partnership for Lazy Eye Detection and Treatment New Technology Gives ‘Second Sight’ to the Blind iPad App for Detecting Retinal Disease Receives Second FDA Approval